Search for a report

ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET FORECAST 2021-2028

  • You are here:
  • Home
  • Downloads
  • ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET FORECAST 2021-2028

ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET FORECAST 2021-2028

The Asia-Pacific hormone replacement therapy market is predicted to register a CAGR of 8.36% during the forecast period, 2021-2028. The surging need for hormone replacement therapy, given the rising awareness among end-users and enhanced healthcare infrastructure regarding hormonal imbalance and menopausal disorders, drives the market growth.

ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET FORECAST 2021-2028

Asia-Pacific Hormone Replacement Therapy Market by Therapy Type (Estrogen Hormone Replacement Therapy, Thyroid Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Progestogen Hormone Replacement Therapy) Market by Indication (Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism, Other Indications) Market by Route of Administration (Oral, Parenteral, Transdermal, Other Route of Administrations) by Geography.

Request free sample

The Asia-Pacific hormone replacement therapy market is predicted to register a CAGR of 8.36% during the forecast period, 2021-2028. The surging need for hormone replacement therapy, given the rising awareness among end-users and enhanced healthcare infrastructure regarding hormonal imbalance and menopausal disorders, drives the market growth.asia-pacific-hormone-replacement-therapy-market

To learn more about this report, request a free sample copy

The Asia-Pacific hormone replacement therapy market growth analysis includes the assessment of India, Japan, Indonesia, Australia & New Zealand, Vietnam, Indonesia, Thailand, South Korea, China, and Rest of Asia-Pacific. In China, the market growth is attributed to the launch of new drugs and therapies to tackle secondary hyperparathyroidism and new drug developments. Several major players are setting up R&D centers for innovating bio-pharmaceuticals. This is accredited to the availability of cheap labor and advanced infrastructure facilities offered by the government.

In India, the demand for HRT is driven by the increasing elderly population. As per the Indian Menopause Society, almost 65 million women over the menopausal age were affected by menopausal symptoms as of 2018. According to the Lancet study in 2019, breast cancer risks were associated with HRT prescribed for managing menopause, with its effects on health twofold. HRT has registered slow growth in India, given the high prices and the rural-urban divide. At the same time, HRT has made progress in the last decade, with a growing number of women opting for HRT, mostly from metropolitan regions.

Novo Nordisk A/S is a multinational pharmaceutical company that develops, produces, and markets pharmaceutical products. It works in areas like hormone replacement therapy. The company markets its products in 170 countries, with 16 production sites in nine countries. It is headquartered in Plainsboro.

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


    1. RESEARCH SCOPE & METHODOLOGY
      • STUDY OBJECTIVES
      • SCOPE OF STUDY
      • METHODOLOGY
      • ASSUMPTIONS & LIMITATIONS
    2. EXECUTIVE SUMMARY
      • MARKET SIZE & ESTIMATES
      • MARKET OVERVIEW
    3. MARKET DYNAMICS
      • KEY DRIVERS
        • PREVAILING AWARENESS ABOUT POST-MENOPAUSAL ISSUES AMONG WOMEN
        • INCIDENCE OF HORMONAL DISORDERS
        • PRODUCT LAUNCHES BY MAJOR PLAYERS
      • KEY RESTRAINTS
        • ADVERSE REACTIONS ASSOCIATED WITH HORMONE REPLACEMENT THERAPY
        • HIGH COST OF TREATMENT
    1. KEY ANALYTICS
      • IMPACT OF COVID-19 ON HORMONE REPLACEMENT THERAPY MARKET
      • KEY MARKET TRENDS
      • PORTER’S FIVE FORCES ANALYSIS
        • BUYERS POWER
        • SUPPLIERS POWER
        • SUBSTITUTION
        • NEW ENTRY
        • INDUSTRY RIVALRY
      • OPPORTUNITY MATRIX
      • VENDOR LANDSCAPE
    2. MARKET BY THERAPY TYPE
      • ESTROGEN HORMONE REPLACEMENT THERAPY
      • THYROID HORMONE REPLACEMENT THERAPY
      • TESTOSTERONE HORMONE REPLACEMENT THERAPY
      • HUMAN GROWTH HORMONE REPLACEMENT THERAPY
      • PROGESTOGEN HORMONE REPLACEMENT THERAPY
    3. MARKET BY INDICATION
      • MENOPAUSE
      • MALE HYPOGONADISM
      • GROWTH HORMONE DEFICIENCY
      • HYPOTHYROIDISM
      • OTHER INDICATIONS
    4. MARKET BY ROUTE OF ADMINISTRATION
      • ORAL
      • PARENTERAL
      • TRANSDERMAL
      • OTHER ROUTE OF ADMINISTRATIONS
    5. GEOGRAPHICAL ANALYSIS
      • ASIA-PACIFIC
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • CHINA
          • JAPAN
          • INDIA
          • AUSTRALIA & NEW ZEALAND
          • SOUTH KOREA
          • INDONESIA
          • THAILAND
          • VIETNAM
          • REST OF ASIA-PACIFIC
    1. COMPETITIVE LANDSCAPE
      • KEY STRATEGIC DEVELOPMENTS
        • MERGERS & ACQUISITIONS
        • PRODUCT LAUNCHES & DEVELOPMENTS
        • PARTNERSHIPS & AGREEMENTS
        • BUSINESS EXPANSIONS, ANNOUNCEMENTS & DIVESTITURES
      • COMPANY PROFILES
        • ABBOTT LABORATORIES
        • AMGEN
        • ANI PHARMACEUTICALS
        • BAYER AG
        • ELI LILLY & COMPANY
        • GENENTECH INC
        • IPSEN
        • MERCK KGAA
        • NOVARTIS AG
        • NOVEN PHARMACEUTICALS INC
        • NOVO NORDISK A/S
        • PFIZER INC
        • VIATRIS INC (MYLAN NV)

    LIST OF TABLES

    TABLE 1: MARKET SNAPSHOT – HORMONE REPLACEMENT THERAPY

    TABLE 2: ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, BY THERAPY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 3: ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, BY THERAPY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 4: ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, BY INDICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 5: ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, BY INDICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 6: ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, BY ROUTE OF ADMINISTRATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 7: ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, BY ROUTE OF ADMINISTRATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 8: ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 9: ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 10: LEADING PLAYERS OPERATING IN ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET

    TABLE 11: LIST OF MERGERS & ACQUISITIONS

    TABLE 12: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

    TABLE 13: LIST OF PARTNERSHIPS & AGREEMENTS

    TABLE 14: LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES

    LIST OF FIGURES

    FIGURE 1: KEY MARKET TRENDS

    FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

    FIGURE 3: OPPORTUNITY MATRIX

    FIGURE 4: VENDOR LANDSCAPE

    FIGURE 5: ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, BY THERAPY TYPE, IN 2020

    FIGURE 6: ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, BY ESTROGEN HORMONE REPLACEMENT THERAPY, 2021-2028 (IN $ MILLION)

    FIGURE 7: ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, BY THYROID HORMONE REPLACEMENT THERAPY, 2021-2028 (IN $ MILLION)

    FIGURE 8: ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, BY TESTOSTERONE HORMONE REPLACEMENT THERAPY, 2021-2028 (IN $ MILLION)

    FIGURE 9: ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, BY HUMAN GROWTH HORMONE REPLACEMENT THERAPY, 2021-2028 (IN $ MILLION)

    FIGURE 10: ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, BY PROGESTOGEN HORMONE REPLACEMENT THERAPY, 2021-2028 (IN $ MILLION)

    FIGURE 11: ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, BY INDICATION, IN 2020

    FIGURE 12: ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, BY MENOPAUSE, 2021-2028 (IN $ MILLION)

    FIGURE 13: ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, BY MALE HYPOGONADISM, 2021-2028 (IN $ MILLION)

    FIGURE 14: ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, BY GROWTH HORMONE DEFICIENCY, 2021-2028 (IN $ MILLION)

    FIGURE 15: ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, BY HYPOTHYROIDISM, 2021-2028 (IN $ MILLION)

    FIGURE 16: ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, BY OTHER INDICATIONS, 2021-2028 (IN $ MILLION)

    FIGURE 17: ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, BY ROUTE OF ADMINISTRATION, IN 2020

    FIGURE 18: ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, BY ORAL, 2021-2028 (IN $ MILLION)

    FIGURE 19: ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, BY PARENTERAL, 2021-2028 (IN $ MILLION)

    FIGURE 20: ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, BY TRANSDERMAL, 2021-2028 (IN $ MILLION)

    FIGURE 21: ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, BY OTHER ROUTE OF ADMINISTRATIONS, 2021-2028 (IN $ MILLION)

    FIGURE 22: ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)

    FIGURE 23: CHINA HORMONE REPLACEMENT THERAPY MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 24: JAPAN HORMONE REPLACEMENT THERAPY MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 25: INDIA HORMONE REPLACEMENT THERAPY MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 26: AUSTRALIA & NEW ZEALAND HORMONE REPLACEMENT THERAPY MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 27: SOUTH KOREA HORMONE REPLACEMENT THERAPY MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 28: INDONESIA HORMONE REPLACEMENT THERAPY MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 29: THAILAND HORMONE REPLACEMENT THERAPY MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 30: VIETNAM HORMONE REPLACEMENT THERAPY MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 31: REST OF ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, 2021-2028 (IN $ MILLION)

    1. GEOGRAPHICAL ANALYSIS
      • ASIA-PACIFIC
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • CHINA
          • JAPAN
          • INDIA
          • AUSTRALIA & NEW ZEALAND
          • SOUTH KOREA
          • INDONESIA
          • THAILAND
          • VIETNAM
          • REST OF ASIA-PACIFIC
    1. MARKET BY THERAPY TYPE
      • ESTROGEN HORMONE REPLACEMENT THERAPY
      • THYROID HORMONE REPLACEMENT THERAPY
      • TESTOSTERONE HORMONE REPLACEMENT THERAPY
      • HUMAN GROWTH HORMONE REPLACEMENT THERAPY
      • PROGESTOGEN HORMONE REPLACEMENT THERAPY
    2. MARKET BY INDICATION
      • MENOPAUSE
      • MALE HYPOGONADISM
      • GROWTH HORMONE DEFICIENCY
      • HYPOTHYROIDISM
      • OTHER INDICATIONS
    3. MARKET BY ROUTE OF ADMINISTRATION
      • ORAL
      • PARENTERAL
      • TRANSDERMAL
      • OTHER ROUTE OF ADMINISTRATIONS

    To request a free sample copy of this report, please complete the form below :
    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


      Choose License Type

      Buy Now